SIA
RMD icon

SkyView Investment Advisors’s ResMed RMD Stock Holding History

SkyView Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,610
Closed -$637K – 332
2024
Q3 		$637K Buy
2,610
+51
+2% +$11.4K 0.11% 155
2024
Q2 		$490K Buy
2,559
+21
+0.8% +$4.26K 0.09% 197
2024
Q1 		$503K Buy
+2,538
New +$465K 0.09% 186
2023
Q4 		– Sell
-1,896
Closed -$281K – 427
2023
Q3 		$281K Buy
1,896
+157
+9% +$28.4K 0.11% 225
2023
Q2 		$380K Sell
1,739
-1,188
-41% -$265K 0.09% 270
2023
Q1 		$641K Buy
2,927
+531
+22% +$115K 0.15% 179
2022
Q4 		$499K Sell
2,396
-306
-11% -$67.2K 0.15% 206
2022
Q3 		$590K Buy
2,702
+486
+22% +$111K 0.17% 193
2022
Q2 		$465K Buy
2,216
+3
+0.1% +$639 0.12% 249
2022
Q1 		$537K Sell
2,213
-12,113
-85% -$2.93M 0.13% 233
2021
Q4 		$507K Buy
14,326
+12,782
+828% +$3.32M 0.11% 222
2021
Q3 		$407K Buy
1,544
+1,533
+13,936% +$419K 0.11% 211
2021
Q2 		$2K Hold
11
– – ﹤0.01% 274
2021
Q1 		$2K Hold
11
– – ﹤0.01% 282
2020
Q4 		$2K Buy
+11
New +$2.19K ﹤0.01% 278

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

SkyView Investment Advisors's RMD Position: Q4 2024 in Review

SkyView Investment Advisors sold out of ResMed (RMD) in Q4 2024, closing a stake of 2,610 shares — an estimated $637K sold.

SkyView Investment Advisors first reported a position in RMD in Q4 2020 and held it in 15 quarters. The position peaked at $641K in Q1 2023. 871 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

  • SkyView Investment Advisors reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
  • SkyView Investment Advisors sold 2,610 ResMed shares in Q4 2024, an estimated $637K.
  • SkyView Investment Advisors first reported a position in ResMed in Q4 2020 and held it in 15 quarters.
  • SkyView Investment Advisors's ResMed position peaked at $641K in Q1 2023.
  • 871 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on SkyView Investment Advisors's 13F filing for Q4 2024, filed 2 Jun 2025.